Emerging role of RNA sensors in tumor microenvironment and immunotherapy

Rui Yang1, Sihui Yu1, Tianhan Xu1

  • 1Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

Insights

RNA sensors are key players in anti-tumor immunity by activating immune responses within the tumor microenvironment. Targeting these sensors offers promising strategies for enhancing cancer immunotherapy effectiveness.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • RNA sensors are crucial for host defense, initiating innate and adaptive immune responses.
  • In the tumor microenvironment (TME), RNA sensor activation promotes anti-tumor immunity and counteracts immunosuppression via type I interferon signaling.
  • Understanding RNA sensor roles in the TME is vital for advancing cancer immunotherapy.

Purpose of the Study:

  • To review the diverse mechanisms of RNA sensors in cancer immunity.
  • To highlight the emerging contributions of RNA sensors in cancer immunotherapy.
  • To explore RNA sensors as potential targets for synergistic cancer treatments.

Main Methods:

  • Literature review of RNA sensor functions in cancer immunity.
  • Analysis of RNA sensor mechanisms in the tumor microenvironment.
  • Synthesis of current research on RNA sensors in various cancer immunotherapy strategies.

Main Results:

  • RNA sensor activation in TME stimulates cytotoxic T lymphocyte responses.
  • Activation of RNA sensors inhibits immunosuppressive cells through type I IFN signaling.
  • RNA sensors demonstrate potential as targets for monotherapy and combination treatments.

Conclusions:

  • RNA sensors are critical regulators of anti-tumor immunity.
  • Targeting RNA sensors presents a promising avenue for novel cancer immunotherapies.
  • RNA sensors can synergize with existing treatments like chemotherapy, radiotherapy, and immune checkpoint blockade.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
691
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
136